基底细胞癌观察等待策略与肿瘤行为的评估:89例患者280个基底细胞癌的观察性队列研究
单中心观察性队列研究纳入89例患者共280个未治疗基底细胞癌,中位随访9个月;多数患者因合并症、衰弱或预期寿命有限选择观察等待,仅47%肿瘤增大,侵袭性亚型与生长相关。
要点
- 观察等待适用于无症状结节/浅表型基底细胞癌且预期寿命有限者。
- 含侵袭性/微结节成分的基底细胞癌年直径增长估计4.46mm,其余仅1.06mm。
- 需定期随访以评估观察等待是否仍合适及患者偏好变化。
核心结论
- 观察等待对部分基底细胞癌患者是合适策略,尤其无症状结节或浅表型且预期寿命有限者。
主要发现
- 中位随访9个月(IQR 4-15),患者中位年龄83岁(IQR 73-88),47%肿瘤增大。
- 含侵袭性/微结节成分者年直径增长估计4.46mm(80%预测区间1.42-7.46),其余为1.06mm(80%预测区间-1.79-4.28)。
关键数值与推荐
- 患者相关因素或偏好是74例(83%)选择观察等待的原因,肿瘤相关因素49例(55%)。
- 治疗相关和情境原因分别对35%和46%的患者重要。
临床怎么用
- 对无症状结节或浅表型基底细胞癌且预期寿命有限者可考虑观察等待。
- 应定期随访以判断观察等待是否仍合适及患者偏好是否变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Few studies have examined watchful waiting (WW) in patients with basal cell carcinoma (BCC), although this approach might be suitable in patients who might not live long enough to benefit from treatment. OBJECTIVE: To evaluate reasons for WW and to document the natural course of BCC in patients who chose WW and reasons to initiate later treatment. DESIGN, SETTING, AND PARTICIPANTS: An observational cohort study was performed at a single institution between January 2018 and November 2020 studying patients with 1 or more untreated BCC for 3 months or longer. EXPOSURES: Watchful waiting was chosen by patients and proxies regardless of this study. MAIN OUTCOME AND MEASURES: The reasons for WW and treatment were extracted from patient files and were categorized for analyses. Linear mixed models were used to estimate tumor growth and identify covariates associated with tumor growth. RESULTS: Watchful waiting was chosen for 280 BCCs in 89 patients (47 men [53%] and 42 women [47%]), with a median (interquartile range [IQR]) follow-up of 9 (4-15) months. The median (IQR) age of the included patients was 83 (73-88) years. Patient-related factors or preferences (ie, prioritizations of comorbidities, severe frailty, or limited life expectancy) were reasons to initiate WW in 74 (83%) patients, followed by tumor-related factors (n = 49; 55%). Treatment-related and circumstantial reasons were important for 35% and 46% of the patients, respectively. The minority of tumors increased in size (47%). Tumor growth was associated with BCC subtype (odds ratio, 3.35; 95% CI, 1.47-7.96; P = .005), but not with initial tumor size and location. The estimated tumor diameter increase was 4.46 mm (80% prediction interval, 1.42 to 7.46 mm) in 1 year for BCCs containing at least an infiltrative/micronodular component and 1.06 mm (80% prediction interval, -1.79 to 4.28 mm) for the remaining BCCs (only nodular/superficial component/clinical diagnosis). Most common reasons to initiate treatment were tumor burden or potential tumor burden, resolved reason(s) for WW, and reevaluation of patient-related factors. CONCLUSIONS AND RELEVANCE: In this cohort study of patients with BCC, WW was an appropriate approach in several patients, especially those with asymptomatic nodular or superficial BCCs and a limited life expectancy. Patients should be followed up regularly to determine whether a WW approach is still suitable and whether patients still prefer WW and to reconsider consequences of treatment and refraining from treatment.
引用
- van Winden MEC, Hetterschijt CRM, Bronkhorst EM, et al. Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma: An Observational Cohort Study of 280 Basal Cell Carcinomas in 89 Patients. JAMA Dermatol. 2021. PMID: 34495284. doi:10.1001/jamadermatol.2021.3020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。